Voices From AdvaMed 2015: Mick Farrell On Going All In With Digital Health
This article was originally published in The Gray Sheet
ResMed's sleep-apnea devices are 100% cloud-connected, and the firm has licensing agreements with companies like Nintendo and makes a sleep monitoring system sold at Apple stores. In this "Gray Sheet" podcast from AdvaMed 2015, CEO Mick Farrell talks about reinventing his firm around data and digital health, and how the broader industry must do the same.
You may also be interested in...
Novartis’s cancer drug has now been filed for multiple sclerosis in the US, armed with a priority review, and in Europe.
Aetion is also working with the US Food and Drug Administration and a number of biopharma companies on projects involving use of real-world evidence.
Increased fines and penalties are on the cards for manufacturing facilities that fail to comply with proposed new requirements.